Recruiting Epcoritamab in Previously Treated WM NCT06510491 Conditions B-Cell Lymphoproliferative Disorder, Blood Protein Disorders, Cardiovascular Diseases, +14 more Locations Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States Dana-Farber Cancer Institute — Boston, Massachusetts, United States University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States View Trial Details
Recruiting A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia NCT06986174 Conditions B-Cell Lymphoproliferative Disorder, Blood Protein Disorders, Cardiovascular Diseases, +21 more Locations Dana Farber Cancer Institute — Boston, Massachusetts, United States View Trial Details
Completed Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx IGH Assay NCT06112301 Conditions B-Cell Lymphoproliferative Disorder Locations Invivoscribe, Inc. — San Diego, California, United States LabPMM GmbH — Hallbergmoos, Germany LabPMM GK — Kawasaki-shi, Kanagawa, Japan View Trial Details
